Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05849155 · ClinicalTrials.gov registry record
Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition
A clinical trial of Genetic Predisposition, sponsored by St. Jude Children's Research Hospital.
- Recruiting
- Registry status
- 125
- Enrollment target
- 1
- Study location
NCT05849155 is a study of Genetic Predisposition that is actively recruiting participants, run by St. Jude Children's Research Hospital. The registered enrollment target is 125 participants, below the 3,511-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05849155, a study of Genetic Predisposition, is actively recruiting participants, sponsored by St. Jude Children's Research Hospital.
- RECRUITING
- Registry status
- 125 participants
- Enrollment target
- 1
- Study location
Study Summary
Testing children, adolescents, and young adults (CAYA) for a genetic risk for cancer can help with early prevention and detection of cancers through regular follow-ups and medical care. After receiving genetic test results, CAYA may not accurately understand what their results mean, and parents are often unsure about talking with their CAYA about their genetic risk for cancer. By understanding how parents communicate with their CAYA, the investigators can improve future genetic education to reduce cancer risk. Primary Objectives: * Identify qualities of parent-CAYA (child, adolescent, and young adults) communication about CAYAs' genomic cancer risk, and their association with CAYAs' psychosocial and prevention outcomes. * Examine the association between sociodemographic, cancer-related, and psychosocial factors and parent-CAYA communication regarding CAYAs' genomic risk for cancer. * Identify barriers and facilitators of parent-CAYA communication regarding CAYAs' genomic risk for cancer.
Conditions Studied
Study Locations (1)
Tennessee
- St. Jude Children's Research Hospital - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2023-12-12 |
| Est. Completion | 2028-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05849155
The ClinicalTrials.gov registry entry for NCT05849155 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 125 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,511-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (96% lower). The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Genetic Predisposition appearing as the primary indexed condition, and to 0 interventions.
NCT05849155 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05849155 about?
NCT05849155 is a clinical study titled "Barriers and Facilitators of Parent-Child Communication in Children With Cancer Predisposition". Testing children, adolescents, and young adults (CAYA) for a genetic risk for cancer can help with early prevention and detection of cancers through regular follow-ups and medical care. After receiving genetic test results, CAYA may not accurately understand what their results mean, and parents are ...
What is the current status of trial NCT05849155?
This trial is currently recruiting. The enrollment target is 125 participants. The study started on 2023-12-12. Estimated completion is 2028-10.
What conditions does trial NCT05849155 study?
This clinical trial studies the following conditions: Genetic Predisposition.
Who is sponsoring clinical trial NCT05849155?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05849155 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Predisposition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
RECRUITING
-
Vascular Disease Discovery Protocol
RECRUITING
-
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
RECRUITING · Phase 4
-
Investigating Hereditary Risk In Thoracic Cancers (INHERIT)
RECRUITING
-
Pancreatic Cancer Early Detection Consortium
RECRUITING
-
Pharmacogenomic Contributions to Trihexyphenidyl Biotransformation and Response in Children With Dystonic Cerebral Palsy
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.